Picton Mahoney Asset Management’s AstraZeneca AZN Stock Holding History

Picton Mahoney Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.18M	Buy	11,218 +9,808	+696%	+$1.89M	0.02%	466
2025 Q4	$259K	Buy	+1,410	New	+$247K	﹤0.01%	786
2015 Q2	–	Sell	-3,750	Closed	-$257K	–	297
2015 Q1	$257K	Sell	3,750 -550	-13%	-$38.2K	0.01%	196
2014 Q4	$303K	Buy	4,300 +1,550	+56%	+$111K	0.01%	201
2014 Q3	$196	Buy	+2,750	New	+$201K	0.01%	227

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Picton Mahoney Asset Management's AZN Position: Q1 2026 in Review

Picton Mahoney Asset Management increased its AstraZeneca (AZN) stake by 696% in Q1 2026, buying an estimated $1.89M and bringing the position to 11,218 shares worth $2.18M. The position accounts for 0.02% of the portfolio, ranked #466.

Picton Mahoney Asset Management first reported a position in AZN in Q3 2014 and has held it in 5 quarters since. 1,382 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Picton Mahoney Asset Management held 11,218 shares of AstraZeneca worth $2.18M as of Q1 2026.
Picton Mahoney Asset Management bought 9,808 AstraZeneca shares in Q1 2026, an estimated $1.89M.
AstraZeneca made up 0.02% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #466 holding.
Picton Mahoney Asset Management first reported a position in AstraZeneca in Q3 2014 and has held it in 5 quarters since.
1,382 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.